login
login

Europe Daily Bulletin No. 12702

21 April 2021
EU RESPONSE TO COVID-19 / Health
European Medicines Agency recommends adding unusual thrombosis to list of very rare side effects of Johnson & Johnson vaccine
Brussels, 20/04/2021 (Agence Europe)

The European Medicines Agency (EMA) gave its verdict, on Tuesday 20 April, on the Covid-19 vaccine produced by Johnson & Johnson: unusual thrombosis with low blood platelets should be included in the list of very rare side effects associated with this vaccine.

This is similar to the verdict given earlier this month for the AstraZeneca vaccine (see EUROPE B12693A1). As with AstraZeneca, the benefits outweigh the identified risks, the European Agency insists.

The agency’s executive...

Contents

EU RESPONSE TO COVID-19
SECTORAL POLICIES
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COURT OF JUSTICE OF THE EU
COUNCIL OF EUROPE
NEWS BRIEFS